Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Sales | 848 | 1,300 | 1,159 | 1,011 | 854 |
| Cost of Goods | 380 | 520 | 550 | 480 | 350 |
| Gross Profit | 460 | 770 | 533 | 520 | 500 |
| Operating Expenses | 1,030 | 1,120 | 730 | 1,100 | 970 |
| Operating Income | -182 | 180 | 429 | -89 | -116 |
| Interest Expense | 10 | 10 | 30 | 10 | 10 |
| Other Income | -8 | -20 | -176 | -1 | -4 |
| Pre-tax Income | -200 | 150 | 223 | -100 | -130 |
| Net Income Continuous | -205 | 152 | 187 | -107 | -135 |
| Net Income | $-205 | $152 | $187 | $-107 | $-135 |
| EPS Basic Total Ops | -0.09 | 0.06 | 0.07 | -0.05 | -0.06 |
| EPS Basic Continuous Ops | -0.09 | 0.07 | 0.08 | -0.05 | -0.06 |
| EPS Diluted Total Ops | -0.09 | 0.06 | 0.07 | -0.05 | -0.06 |
| EPS Diluted Continuous Ops | -0.09 | 0.07 | 0.08 | -0.05 | -0.06 |
| EBITDA(a) | $-162 | $200 | $429 | $-69 | $-86 |